Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (8)
Bone Marrow Transplantation (7)
Blood Cancer Journal (2)
Nature Communications (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (18)
Correspondence (2)

Subject Check one or more subjects to show results from those subjects only.

Biological techniques
Cancer
Diseases
Genetics
Health care
Immunology
Medical research
Oncology
Pathogenesis
Risk factors

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–20 of 20 results

Advanced filters: Author: Marco Ladetto Clear advanced filters

Stem cell collection and hematological recovery in the Fondazione Italiana Linfomi (FIL) MCL0208 clinical trial

Michele Clerico
Simone Ferrero
Marco Ladetto
ResearchOpen Access23 Jul 2024
Scientific Reports

Volume: 14, P: 1-9
Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies

Andreas Trojan
Joachim L. Schultze
John G. Gribben
Research01 Jun 2000
Nature Medicine

Volume: 6, P: 667-672
Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial

M Ladetto
S Vallet
C Tarella
Research24 Aug 2006
Leukemia

Volume: 20, P: 1840-1847
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial

Riccardo Moia
Simone Ragaini
Simone Ferrero
ResearchOpen Access07 Nov 2025
Leukemia

Volume: 40, P: 219-223
Incidence and outcome of Kaposi sarcoma after hematopoietic stem cell transplantation: a retrospective analysis and a review of the literature, on behalf of infectious diseases working party of EBMT

Simone Cesaro
Gloria Tridello
Jan Styczynski
Research21 Aug 2019
Bone Marrow Transplantation

Volume: 55, P: 110-116
Reduced intensity versus myeloablative conditioning for MDS: long-term results of an EBMT phase III study (RICMAC)

Christian Niederwieser
Simona Iacobelli
Nicolaus Kröger
ResearchOpen Access25 Apr 2024
Bone Marrow Transplantation

Volume: 59, P: 1084-1091
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)

Gabriel Scheubeck
Linmiao Jiang
Eva Hoster
ResearchOpen Access26 Jul 2023
Leukemia

Volume: 37, P: 1887-1894
Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT

Mitja Nabergoj
Katya Mauff
Ibrahim Yakoub-Agha
Research06 Apr 2021
Bone Marrow Transplantation

Volume: 56, P: 1944-1952
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial

Mouhamad Khouja
Elisa Genuardi
Maria Gomes da Silva
ResearchOpen Access03 Nov 2025
Leukemia

Volume: 40, P: 95-105
Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients

Cinzia Borgogna
Riccardo Bruna
Marisa Gariglio
ResearchOpen Access18 Jan 2022
Blood Cancer Journal

Volume: 12, P: 1-6
Epigenomic evolution in diffuse large B-cell lymphomas

The contribution of epigenomic alterations to tumour progression and relapse is not well characterized. Here the authors characterize epigenetic evolution in aggressive B-cell lymphoma and find that epigenomic heterogeneity may not only support and drive the relapse phenotype but also be used to predict lymphoma relapse.

Heng Pan
Yanwen Jiang
Olivier Elemento
ResearchOpen Access20 Apr 2015
Nature Communications

Volume: 6, P: 1-12
Daratumumab for PRCA after HCT: study and practical considerations from the EBMT Transplant Complications Working Party

Nico Gagelmann
Moniek de Witte
Zinaida Peric
ResearchOpen Access04 Jun 2025
Blood Cancer Journal

Volume: 15, P: 1-8
Methods and role of minimal residual disease after stem cell transplantation

Marco Ladetto
Sebastian Böttcher
Peter Bader
Research16 Aug 2018
Bone Marrow Transplantation

Volume: 54, P: 681-690
Real-world study in steroid-refractory acute graft versus host disease: Comparison of efficacy and tolerability of ruxolitinib alone or ruxolitinib in association with extracorporeal photopheresis or extracorporeal photopheresis monotherapy

Marta Lisa Battista
Gabriele Facchin
Francesca Patriarca
Correspondence26 Jul 2025
Bone Marrow Transplantation

Volume: 60, P: 1406-1409
Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia

D Rossi
C Lobetti Bodoni
M Ladetto
Research02 Apr 2009
Leukemia

Volume: 23, P: 1062-1072
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders

M Ladetto
M Brüggemann
C Pott
Research17 Dec 2013
Leukemia

Volume: 28, P: 1299-1307
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

Sebastian Giebel
Myriam Labopin
Depei Wu
Research05 Sept 2020
Bone Marrow Transplantation

Volume: 56, P: 481-491
Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients

I Ricca
A Rocci
M Ladetto
Research15 Feb 2007
Leukemia

Volume: 21, P: 697-705
Upfront intensive chemo-immunotherapy with autograft in 199 adult mantle cell lymphoma patients: prolonged survival and cure potentiality at long term

Sergio Cortelazzo
Michael Mian
Corrado Tarella
CorrespondenceOpen Access07 Jul 2021
Bone Marrow Transplantation

Volume: 56, P: 2606-2609
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF

I Ricca
M Compagno
C Tarella
Research17 Feb 2005
Leukemia

Volume: 19, P: 644-651